Placental transmission of thyroid-stimulating immunoglobulins.
作者信息
Dirmikis S M, Munro D S
出版信息
Br Med J. 1975 Jun 21;2(5972):665-6. doi: 10.1136/bmj.2.5972.665.
Abstract
Long-acting thyroid stimulator (LATS) and LATS protector (LATS-P) were assayed at or near delivery in serum from 18 pregnant women with a history of past or present thyrotoxicosis. The results suggested that neonatal thyrotoxicosis may be predicted prenatally if maternal serum LATS and LATS-P concentrations near delivery are above certain levels.
摘要
相似文献
1
Placental transmission of thyroid-stimulating immunoglobulins.
Br Med J. 1975 Jun 21;2(5972):665-6. doi: 10.1136/bmj.2.5972.665.
2
Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
J Clin Endocrinol Metab. 1982 Feb;54(2):354-6. doi: 10.1210/jcem-54-2-354.
3
The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.
Br J Obstet Gynaecol. 1978 Nov;85(11):837-43. doi: 10.1111/j.1471-0528.1978.tb15839.x.
4
Letter: Placental transmission of L. A. T. S. protector.
Lancet. 1974 Dec 28;2(7896):1579-80. doi: 10.1016/s0140-6736(74)90335-3.
5
The role of long acting thyroid stimulator in neonatal thyrotoxicosis.
Clin Endocrinol (Oxf). 1972 Jan;1(1):81-90. doi: 10.1111/j.1365-2265.1972.tb00380.x.
6
Neonatal thyrotoxicosis: alterations in serum concentrations of LATS-protector, T4, T3, reverse T3, and 3,3'T2.
J Pediatr. 1978 Jul;93(1):118-20. doi: 10.1016/s0022-3476(78)80620-9.
7
Humoral and genetic factors in thyrotoxic Graves disease and neonatal thyrotoxicosis.
JAMA. 1976 Apr 5;235(14):1449-50.
8
["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Schweiz Med Wochenschr. 1968 Jan 6;98(1):8-12.
9
[Non-fatal case of neonatal thyrotoxicosis with serial determination of LATS].
Horumon To Rinsho. 1970 May;18(5):417-20.
10
Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).
Arch Dis Child. 1976 Jul;51(7):565-7. doi: 10.1136/adc.51.7.565.
引用本文的文献
1
Thyroid-stimulating immunoglobulins in neonatal Graves's disease.
Arch Dis Child. 1980 Nov;55(11):894-5. doi: 10.1136/adc.55.11.894.
2
Hyperemesis gravidarum due to thyrotoxicosis.
Postgrad Med J. 1980 Oct;56(660):746-7. doi: 10.1136/pgmj.56.660.746.
3
Management of endocrine disorders in pregnancy Part I--thyroid and parathyroid disease.
Postgrad Med J. 1984 Apr;60(702):245-52. doi: 10.1136/pgmj.60.702.245.
4
The thyrotrophin receptor.
Springer Semin Immunopathol. 1982;5(4):413-31. doi: 10.1007/BF01857428.
5
Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
Clin Exp Immunol. 1983 May;52(2):317-24.
6
Thyroid disease in pregnancy.
Br Med J (Clin Res Ed). 1987 Jan 31;294(6567):264-5. doi: 10.1136/bmj.294.6567.264.
7
Attempted prevention of neonatal thyrotoxicosis.
Br Med J. 1976 Nov 6;2(6044):1110. doi: 10.1136/bmj.2.6044.1110.
8
Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).
Arch Dis Child. 1976 Jul;51(7):565-7. doi: 10.1136/adc.51.7.565.
9
Prenatal treatment of fetal thyrotoxicosis.
Br Med J. 1979 Feb 10;1(6160):383-4. doi: 10.1136/bmj.1.6160.383-a.
10
Pathogenesis of neonatal Graves' disease.
J Endocrinol Invest. 1978 Apr;1(2):183-9. doi: 10.1007/BF03350370.
本文引用的文献
1
The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro.
J Endocrinol. 1970 Jan;46(1):45-54. doi: 10.1677/joe.0.0460045.
2
Some factors affecting the detection of long-acting thyroid stimulator protector using the McKenzie bioassay.
J Endocrinol. 1974 Dec;63(3):427-38. doi: 10.1677/joe.0.0630427.
3
Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
J Clin Endocrinol Metab. 1967 Feb;27(2):173-7. doi: 10.1210/jcem-27-2-173.
4
Neonatal thyrotoxicosis associated with maternal hypothyroidism.
Lancet. 1966 Mar 19;1(7438):635-6. doi: 10.1016/s0140-6736(66)90828-2.
5
Letter: Placental transmission of L. A. T. S. protector.
Lancet. 1974 Dec 28;2(7896):1579-80. doi: 10.1016/s0140-6736(74)90335-3.
6
Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator.
J Endocrinol. 1975 Mar;64(3):29P-30P.
7
Letter: Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
Br Med J. 1975 Apr 5;2(5961):36. doi: 10.1136/bmj.2.5961.36-b.
Zotero 插件